{
    "version": "1.0",
    "type": "rich",
    "width": 0,
    "height": 0,
    "html": false,
    "provider_name": "ReleaseWire",
    "provider_url": "http:\/\/www.releasewire.com\/",
    "title": "First U.S. Clinical Site Opens for Cel-Sci's Global Phase III Immunotherapy Head and Neck Cancer Trial Expansion",
    "author_name": "CEL-SCI Corporation",
    "author_url": "http:\/\/www.cel-sci.com"
}